KR20260022421A - 화합물 또는 그의 염 및 그의 제조 방법, 조성물, 과산화수소 제거제, 그리고 세포 독성 억제제 - Google Patents

화합물 또는 그의 염 및 그의 제조 방법, 조성물, 과산화수소 제거제, 그리고 세포 독성 억제제

Info

Publication number
KR20260022421A
KR20260022421A KR1020267000808A KR20267000808A KR20260022421A KR 20260022421 A KR20260022421 A KR 20260022421A KR 1020267000808 A KR1020267000808 A KR 1020267000808A KR 20267000808 A KR20267000808 A KR 20267000808A KR 20260022421 A KR20260022421 A KR 20260022421A
Authority
KR
South Korea
Prior art keywords
mass
less
compound
hydrogen peroxide
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020267000808A
Other languages
English (en)
Korean (ko)
Inventor
준 마츠모토
구니오 고사카
Original Assignee
나가세 상교오 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나가세 상교오 가부시키가이샤 filed Critical 나가세 상교오 가부시키가이샤
Publication of KR20260022421A publication Critical patent/KR20260022421A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020267000808A 2023-06-15 2024-06-12 화합물 또는 그의 염 및 그의 제조 방법, 조성물, 과산화수소 제거제, 그리고 세포 독성 억제제 Pending KR20260022421A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023098209 2023-06-15
JPJP-P-2023-098209 2023-06-15
PCT/JP2024/021265 WO2024257775A1 (ja) 2023-06-15 2024-06-12 化合物又はその塩及びその製造方法、組成物、過酸化水素除去剤、並びに、細胞毒性抑制剤

Publications (1)

Publication Number Publication Date
KR20260022421A true KR20260022421A (ko) 2026-02-19

Family

ID=93852144

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020267000808A Pending KR20260022421A (ko) 2023-06-15 2024-06-12 화합물 또는 그의 염 및 그의 제조 방법, 조성물, 과산화수소 제거제, 그리고 세포 독성 억제제

Country Status (5)

Country Link
EP (1) EP4729511A1 (https=)
JP (1) JP7755772B2 (https=)
KR (1) KR20260022421A (https=)
CN (1) CN121311472A (https=)
WO (1) WO2024257775A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007300916A (ja) * 2006-04-10 2007-11-22 Manabu Nukina エルゴチオネインの製造方法
JP2008156320A (ja) 2006-12-26 2008-07-10 Hydrox Kk 抗酸化性機能水
CN109091422B (zh) 2018-08-01 2021-06-04 上海应用技术大学 含榆黄菇提取液的化妆品及其制备方法
CN109293572A (zh) 2018-09-26 2019-02-01 上海市农业科学院 一种提取榆黄菇中麦角硫因与多糖的方法
JP2020103100A (ja) 2018-12-27 2020-07-09 小林製薬株式会社 細胞内の抗酸化機能亢進剤
JP6864131B1 (ja) 2020-03-04 2021-04-28 長瀬産業株式会社 Ｌ−エルゴチオネイン含有組成物

Also Published As

Publication number Publication date
JP7755772B2 (ja) 2025-10-16
WO2024257775A1 (ja) 2024-12-19
EP4729511A1 (en) 2026-04-22
JPWO2024257775A1 (https=) 2024-12-19
CN121311472A (zh) 2026-01-09

Similar Documents

Publication Publication Date Title
MX2022000854A (es) Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr.
GEAP202416075A (en) New macrocyclic lrrk2 kinase inhibitors
UY29702A1 (es) Inhibidores macrocíclicos del virus de hepatitis c
BR0208253A (pt) Compostos, composições farmacêuticas, método de preparação de composições farmacêuticas, processo para preparação de compostos, e, uso de um composto
NO341631B1 (no) Hydroksybenzamidderivater og deres anvendelse, fremgangsmåte for fremstilling og farmasøytiske sammensetninger
HRP20050944A2 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
BR0111230A (pt) Composto, e, uso e processo para a preparação do mesmo
ATE457981T1 (de) 3-amido-1,2-benzisoxazolderivate, herstellungsverfahren und deren verwendung
DE602004005960D1 (de) Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten
SE0403171D0 (sv) New compounds
MX2025004959A (es) Derivados de triazinona como inhibidores de inflamasoma de proteina 3 que contiene dominios de pirina (nlrp3)
KR20260022421A (ko) 화합물 또는 그의 염 및 그의 제조 방법, 조성물, 과산화수소 제거제, 그리고 세포 독성 억제제
BRPI0418047B8 (pt) Processo para a preparação de derivados de piridina e composto intermediário
MXPA06000986A (es) Compuestos.
MX2023015408A (es) Inhibidores de transglutaminasas.
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
WO2008114622A1 (ja) 酸化発色化合物またはその塩およびその製造方法、ならびに試薬組成物およびこれを用いた試験具
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
Sasaki et al. Structure-activity relationships of biflavonoids for β-secretase (bace-1) inhibitory activity
ATE316972T1 (de) Trizyklische crf rezeptor antagonisten
AR052302A1 (es) Derivados de sulfonamidas, procesos de preparacion y composiciones farmaceuticas que los contienen
EA200500716A1 (ru) Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат
KR101803218B1 (ko) 형광단 3-하이드록시플라본
WO2025165846A1 (en) Rhodoquinone mimetics and methods of making and using thereof

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-NAP-PG1501 (AS PROVIDED BY THE NATIONAL OFFICE)